Introduction
Patients with epilepsy respond differently to medications. Approximately 20-30% of patients with epilepsy have drugresistant epilepsy, and epilepsy surgery is the treatment of choice for the refractory epilepsy. However, after a follow-up of 5 years, the number of patients remaining seizure-free begins to decline, [1] [2] [3] [4] consistent with our recent results. 4 In addition, not all patients with similar seizure types and epileptogenic focus localizations become seizure-free after surgery. This indicates that the mechanisms underlying poor postoperative outcomes are unclear. Therefore, it would be compelling to identify predictive factors of postoperative seizure outcomes. The hippocampus is a highly sophisticated structure, including CA1-CA4 subfields, dentate gyrus (DG), fimbria, subiculum (SUB), parasubiculum, and entorhinal cortex (ERC). 5 Hippocampal sclerosis (HS) is a pathological hallmark of mesial temporal lobe epilepsy (MTLE). MTLE due to HS are more frequently drug resistant. Tailored resection strategies, including selective amygdalohippocampectomies and standard temporal lobectomies, are established treatment modalities. The postoperative seizure freedom rate in patients with MTLE due to HS is approximately 56-91%. 1, 3, 6, 7 Neuropathological investigations indicate that HS is not a single entity. Neuron loss can be detected within different hippocampal subfields (CA1-CA4, DG). Thus, HS can be separated into distinct pathological subgroups according to its subtle differences. 8, 9 International League Against Epilepsy (ILAE) has reported a new classification of HS. 10 Different types of HS may be associated with different clinical phenotypes and postoperative outcomes. 11, 12 However, the association of long-term postoperative seizure outcomes with different HS types has never been reported. Our aim was to assess the correlation between HS ILAE types and postoperative seizure outcome in a cohort of 100 patients with MTLE due to HS.
Methods

Study population
This study was approved by the Institutional Review Board of the First Affiliated Hospital of Harbin Medical University, and the participants gave informed consent. For the minors/children enrolled in our study, we obtained the written informed consent from the next of kin, caretakers, or guardians on behalf of them. A total of 100 patients were included in the Department of Neurosurgery at the First Affiliated Hospital of Harbin Medical University between 2006 and 2013. All cases were considered to have refractory epilepsy, after at least two first-line anti-epileptic drugs failed. The preoperative evaluation included cognitive and neuropsychological testing, electroencephalogram (EEG), videoelectroencephalographic monitoring, high-resolution hippocampal 1.5 T or 3 T magnetic resonance imaging (MRI), and fluorodeoxy glucose positron emission tomography combined with computed tomography (FDG-PET/CT). The mesio-temporal foci were diagnosed with EEG and 24 h video-electroencephalographic monitoring. Abnormal hippocampal MRI signals, including hippocampal atrophy and temporal horn dilatation on coronal T1-weighted images and increased signal intensity within the hippocampus on T2-weighted images and fluid attenuated inversion recovery (FLAIR) images, could be shown in some patients. However, the other patients indistinctively showed abnormal signals on their hippocampal MRI. Indeed, it is difficult to distinguish the slight atrophy of a single hippocampal subfield on MRI by naked eyes. According to the abnormal spike wave and sharp wave in mesio-temporal lobe on EEG and 24 h-video EEG (VEEG), we performed FDG-PET/CT in patients who had indistinctive abnormal signals on their hippocampal MRI. The low metabolism of mesio-temporal lobe could be detected. The senior author, who has had nearly 15 years of experience in the surgical treatment of intractable epilepsy, was responsible for identifying these findings and the criteria used for diagnosing HS. All patients underwent selective amygdalohippocampectomies or standard anterior temporal lobectomies with amygdalohippocampectomies by the senior author. During operation, cortical electroencephalogram (ECoG) and deep electrodes were used to further identify the abnormal electrical activity. The hippocampal specimens of these patients were collected for pathological and histological research. Postoperative data were obtained from patients' interviews during the postoperative outpatient visits or by telephone interviews at least once per year. The postoperative seizure outcome was evaluated using ILAE outcome classification 13 after 7-year follow-up. The clinical characteristics of patients were categorized ( Table 1 ). The patients were divided into three groups according to their histological results. Seven hippocampal specimens served as controls. Three hippocampal control specimens were obtained from neurologically healthy autopsies and the written consents were given by the next of kin. The other control specimens were obtained from patients who were diagnosed with intracranial space-occupying lesions (tumors or cerebral cavernous malformations) next to the hippocampus and who had only one or two seizures. Hippocampectomies were performed in these patients to avoid postoperative secondary epilepsy. All the procedures were standardized in the framework of the study. The first author participated in all the procedures, and verified by the corresponding author.
Tissue preparation
Hippocampal specimens were dissected into 3-mm-thick slices along the long axis. All tissues were fixed with 10% formalin overnight, and then cut at 4 mm with a microtome (Leica). The sections were mounted onto charged slides, air-dried in an oven at 70 8C for 2 h, cleared in xylene, and deparaffinized in descending alcohol concentrations. The hippocampal pyramidal neurons and granule cells of the DG were immunostained for the neuronal core antigen NeuN. The staining was performed with the streptavidinperoxidase method, and 3,3 0 -diaminobenzidine was added as a chromogen. Hematoxylin counterstaining was finally conducted.
The quantitative measurement method
The quantitative measurement of neuronal cell numbers was employed as previously described. 9 Neuronal cell bodies immunohistochemically stained (NeuN) could be clearly tagged on the computer screen. The neurons were manually counted separately within different hippocampal subfields with a microcomputer imaging system (Leica Application Suite, Version 4. Table 2 ).
The clinicopathological classification system for HS
The ILAE classification system was employed to identify the HS types in our study. 10 According to the semi-quantitative methods, 3 types of HS were classified. HS ILAE type 1 refers always to severe neuronal cell loss and gliosis predominantly in CA1 and CA4 regions, HS ILAE type 2 shows predominant neuronal cell loss and gliosis in CA1 region, HS ILAE type 3 demonstrates predominant neuronal cell loss and gliosis in CA4 region. 
Statistical analysis
SPSS software (Windows, Version 19.0, IBM Corporation, Armonk, NY, USA) was used for the statistical analysis. KaplanMeier curves were used to specify different lengths of follow-up. One variable was measured: the time to the first postoperative seizure. Continuous variables were compared via one-way analysis of variance (ANOVA). Categorical variables were examined by the chi-square test and Fisher's exact test as appropriate. A P value of less than 0.05 was considered statistically significant.
Results
Patient characteristics
A total of 100 patients with MTLE were included in our cohort study. Demographic and clinical characteristics of those patients were categorized (Table 1) . Those characteristics included mean age at surgery, gender, duration between epilepsy and surgery, any initial precipitating injury (IPI), EEG, 24 h-VEEG, hippocampal MRI, head FDG-PET/CT, intro-operation ECoG, intro-operation deep electrodes, side of operation, and bilateral abnormalities.
The characterization of HS in postoperative specimens
The semi-quantitative analysis and NeuN immunohistochemical staining identified 3 different types of HS in the postoperative hippocampal specimens (Fig. 1 and Table 2 
Correlation between HS ILAE types and IPI
The correlation between HS ILAE types and IPI in patients with HS was assessed. The highest incidence of IPI was noted in the HS ILAE type 1 group (53.1%). Most patients in the HS ILAE type 2 and type 3 groups did not have a history of IPI (88.9% and 91.7% respectively). There was the significant correlation between HS ILAE types and IPI among the groups (P < 0.001, Pearson's chisquare test) ( Table 3) .
Correlation between HS ILAE types and epilepsy duration
We also assessed the correlation between HS ILAE types and epilepsy duration. Epilepsy duration was defined as the period from the onset of the first seizure to time of operation. The shortest epilepsy duration was recorded in the HS ILAE type 2 group (mean epilepsy duration = 6.64 AE 5.83 years). However, the patients in HS ILAE type 1 or type 3 group showed longer epilepsy duration (mean epilepsy duration = 15.21 AE 10.33, or 16.92 AE 10.56 years respectively). There was the statistically significant correlation between the HS ILAE types and epilepsy duration among the groups (P < 0.001, variance analysis with one-way ANOVA) ( Table 4 ).
Correlation between HS ILAE types and long-term postoperative seizure outcome
The long-term postoperative seizure outcome in patients with HS was further assessed according to the ILAE outcome classification. Class 1: completely seizure free without auras; class 2: only auras without other seizures; class 3: one to three seizure days per year with or without auras; class 4-6: less favorable seizure outcomes. The postsurgical seizure outcome in patients with HS was obtained every year during the 7-year postoperative follow-up (Fig. 2) . In the first year after surgery, the probability that the patients remaining in class 1, 2, 3, or 4+ were 61.22%, 18.37%, 10.2%, or 10.2% respectively in the HS ILAE type 1 group; the probability that the patients remained in class 1, 2, 3, or 4+ was 40.74%, 29.63%, 11.11%, or 18.52% respectively in the HS ILAE type 2 group; the probability that the patients remained in class 1, 2, 3, or 4+ was 45.83%, 33.33%, 8.33%, or 12.5% respectively in the HS ILAE type 3 group. In the fifth year following surgery, the probability that the patients remained in class 1, 2, 3, or 4+ was 60%, 33.33%, 6.67%, or 0% respectively in the HS ILAE type 1 group; the probability that the patients remained in class 1, 2, 3, or 4+ was 47.37%, 21.05%, 15.79%, or 15.79% respectively in the HS ILAE type 2 group; the probability that the patients remained in class 1, 2, 3, or 4+ was 35.29%, 29.41%, 23.53%, or 11.76% respectively in the HS ILAE type 3 group. In the seventh year after surgery, the probability that the patients remained in class 1, 2, 3, or 4+ was 50%, 30%, 20%, or 0% respectively in the HS ILAE type 1 group; the probability that the patients remained in class 1, 2, 3, or 4+ was 14.29%, 14.29%, 42.86%, or 28.57% respectively in the HS ILAE type 2 group; the probability that the patients remained in class 1, 2, 3, or 4+ was 50%, 16.67%, 16.67%, or 16.67% respectively in the HS ILAE type 3 group. The completely seizure free rate of patients in all groups declined with an increase in time. There was the statistically significant difference in postoperative seizure outcome among the different HS ILAE type groups (P < 0.05, Kaplan-Meier curves). The most favorable long-term seizure outcome was noted in the HS ILAE type 1 group. The poorer outcome was observed in the HS ILAE type 2 and type 3 groups. There was no significant difference in postoperative seizure outcome between the last two groups (Fig. 3) .
Discussion
Our recent study demonstrated that approximately one-third of patients with intractable epilepsy did not become seizure-free after tailored resection strategies. 4 The predictors of seizure outcomes, including IPI, seizure type and frequency, epilepsy duration, MRI and EEG findings, and age at resection, have been identified. 7, 12, [14] [15] [16] [17] [18] [19] [20] [21] Our study for the first time demonstrated a significant correlation between HS ILAE types and long-term postoperative seizure outcome in patients with MTLE due to HS. HS ILAE type 1 was associated with higher rates of postoperative seizure-free. The identification of the clinicopathological correlation will aid in predicting the long-term seizure outcome of patients with MTLE due to HS. IPI has been observed in patients with HS. 22 A correlation between HS and IPI has been previously reported 23 . One study demonstrated that the severe neuronal loss in CA1 region was associated with the occurrence of IPI before the age of seven. More widespread hippocampal damage comprising all hippocampal subfields was caused by earlier IPI under the age of 3 years. 9 HS and febrile seizures were associated with a mutation of the SCN1A gene in early childhood. 24 Moreover, dentate granule cell proliferation The analysis of long-term outcomes of temporal lobe epilepsy surgery demonstrated that patients might relapse after many years of being seizure free. McIntosh et al. showed the probability of complete seizure freedom at 10 years after surgery was 41%. 31 Paglioli et al. 2 demonstrated Kaplan-Meier estimates of complete seizure freedom for years 5 and 10 were 74% and 66% respectively. In two recent studies, the seizure free rate at 5 years or 10 years was 55% or 53% respectively. 32, 33 More recently, Mohammed et al.
performed a long-term longitudinal study on epilepsy outcomes (mean: 26 years) in patients with a variety of seizure types, and showed that about 48% of these patients were seizure free. 34 Additionally, Hemb et al. illustrated the probability of remaining completely seizure-free at 12 and 18 years after MTLE/HS surgery was 65% and 62% respectively. 1 However, the precise association between HS ILAE types and long-term postsurgical seizure outcome has been never reported. To ensure the reliability of our study, all MTLE patient data were collected in the same epilepsy center. More importantly, all the operations were performed by the same professor, who has nearly had 15 years of experience in the surgical treatment of epilepsy. In this study, the follow-up period was 7 years, and the ILAE outcome classification system was employed. The higher rates of longterm postoperative seizure-free were observed in the HS ILAE type 1 group. A favorable postsurgical outcome has always been associated with HS severity. 7, [35] [36] [37] [38] [39] Therefore, our results indicated that HS ILAE types could predict the long-term postoperative seizure outcome of patients with MTLE due to HS. There are some limitations in our study. We only assessed the seizure outcome in patients with MTLE. The postoperative outcomes in epilepsy patients should also include other important factors, such as cognition, memory, and psychological condition.
Further separate studies would be informative regarding these postoperative outcomes. Clinical observations are dependent on the accuracy of the case records, and as in all clinicopathologic studies there may be inaccuracies regarding recollection of IPI events and seizure history. In addition, another drawback in this study is lack of the collaboration between neurosurgeons, epileptologists, neuropsychologists, and neuroradiologists.
Conclusion
In conclusion, our study demonstrated a significant association between IPI and HS ILAE type 1. It suggested that IPI has a significant effect on the pathogenesis of HS. In addition, the most favorable long-term postsurgical seizure outcome was observed in the HS ILAE type 1 group, and the shortest epilepsy duration was recorded in the HS ILAE type 2 group. The identification of the clinicopathological correlation will aid in the more accurate prediction of the long-term postsurgical seizure outcome of patients with MTLE due to HS.
